DK1200399T3 - Vitamin D3-analoger - Google Patents

Vitamin D3-analoger

Info

Publication number
DK1200399T3
DK1200399T3 DK00954438T DK00954438T DK1200399T3 DK 1200399 T3 DK1200399 T3 DK 1200399T3 DK 00954438 T DK00954438 T DK 00954438T DK 00954438 T DK00954438 T DK 00954438T DK 1200399 T3 DK1200399 T3 DK 1200399T3
Authority
DK
Denmark
Prior art keywords
analogues
vitamin
Prior art date
Application number
DK00954438T
Other languages
Danish (da)
English (en)
Inventor
Andrew David Batcho
Bernard Michael Hennessy
Milan Radoje Uskokovic
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Application granted granted Critical
Publication of DK1200399T3 publication Critical patent/DK1200399T3/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C401/00Irradiation products of cholesterol or its derivatives; Vitamin D derivatives, 9,10-seco cyclopenta[a]phenanthrene or analogues obtained by chemical preparation without irradiation
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00Drugs for disorders of the urinary system
    • A61P13/08Drugs for disorders of the urinary system of the prostate
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • A61P17/10Anti-acne agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00Drugs for skeletal disorders
    • A61P19/08Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • A61P35/02Antineoplastic agents specific for leukemia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00Drugs for disorders of the endocrine system
    • A61P5/24Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/28Antiandrogens

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Rheumatology (AREA)
  • Diabetes (AREA)
  • Endocrinology (AREA)
  • Oncology (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DK00954438T 1999-07-12 2000-07-06 Vitamin D3-analoger DK1200399T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US14341399P 1999-07-12 1999-07-12
PCT/EP2000/006393 WO2001004089A1 (en) 1999-07-12 2000-07-06 Vitamin d3 analogs

Publications (1)

Publication Number Publication Date
DK1200399T3 true DK1200399T3 (da) 2004-07-19

Family

ID=22503954

Family Applications (1)

Application Number Title Priority Date Filing Date
DK00954438T DK1200399T3 (da) 1999-07-12 2000-07-06 Vitamin D3-analoger

Country Status (36)

Country Link
US (1) US6331642B1 (pl)
EP (1) EP1200399B1 (pl)
JP (1) JP3803579B2 (pl)
KR (1) KR100477161B1 (pl)
CN (1) CN1174964C (pl)
AR (1) AR024695A1 (pl)
AT (1) ATE262508T1 (pl)
AU (1) AU779408B2 (pl)
BR (1) BR0012419A (pl)
CA (1) CA2378803C (pl)
CO (1) CO5190683A1 (pl)
DE (1) DE60009303T2 (pl)
DK (1) DK1200399T3 (pl)
EG (1) EG23909A (pl)
ES (1) ES2215707T3 (pl)
GC (1) GC0000198A (pl)
HK (1) HK1047578B (pl)
HR (1) HRP20020007A2 (pl)
HU (1) HUP0202157A3 (pl)
IL (2) IL147254A0 (pl)
JO (1) JO2255B1 (pl)
MA (1) MA26808A1 (pl)
MX (1) MXPA02000313A (pl)
MY (1) MY122633A (pl)
NO (1) NO20020161L (pl)
NZ (1) NZ516339A (pl)
PE (1) PE20010328A1 (pl)
PL (1) PL201877B1 (pl)
PT (1) PT1200399E (pl)
RS (1) RS50229B (pl)
RU (1) RU2235721C2 (pl)
TR (1) TR200200054T2 (pl)
TW (1) TWI268276B (pl)
UY (1) UY26239A1 (pl)
WO (1) WO2001004089A1 (pl)
ZA (1) ZA200110487B (pl)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2001278744A1 (en) * 2000-08-17 2002-02-25 Chugai Seiyaku Kabushiki Kaisha Remedial agent for osteoporosis
CA2424555A1 (en) 2000-10-02 2002-04-11 Emory University Triptolide analogs for the treatment of autoimmune and inflammatory disorders
CN1285573C (zh) * 2001-09-21 2006-11-22 霍夫曼-拉罗奇有限公司 3-脱氧-维生素d3类似物酯
US7563810B2 (en) 2002-11-06 2009-07-21 Celgene Corporation Methods of using 3-(4-amino-1-oxo-1,3-dihydroisoindol-2-yl)-piperidine-2,6-dione for the treatment and management of myeloproliferative diseases
US8034831B2 (en) 2002-11-06 2011-10-11 Celgene Corporation Methods for the treatment and management of myeloproliferative diseases using 4-(amino)-2-(2,6-Dioxo(3-piperidyl)-isoindoline-1,3-dione in combination with other therapies
CA2524026A1 (en) * 2003-04-30 2004-11-18 Bioxell S.P.A. Gemini vitamin d3 compounds and methods of use thereof
US20050113348A1 (en) * 2003-06-12 2005-05-26 Yanchun Li Vitamin D and vitamin D analogs or derivatives as new anti-hypertensive agents
GB2407499B (en) * 2003-11-03 2008-02-27 Bioxell Spa Vitamin D3 analogue for use in the treatment of BPH
AU2004275845A1 (en) * 2003-09-24 2005-04-07 Bioxell, S.P.A. Methods for treating bladder dysfunction
US7332482B2 (en) * 2003-09-24 2008-02-19 Bioxell S.P.A. Method for treating benign prostatic hyperplasia
US8404667B2 (en) * 2006-12-29 2013-03-26 Wisconsin Alumni Research Foundation Compounds, compositions, kits and methods of use to orally and topically treat acne and other skin conditions by 19-Nor vitamin D analog
AU2005289664A1 (en) * 2004-09-24 2006-04-06 Bioxell S.P.A. 20-cycloalkyl,26,27-alkyl/haloalkyl vitamin D3 compounds and methods of use thereof
JP2008519808A (ja) 2004-11-12 2008-06-12 ビオエクセル エスピーエー 膀胱癌治療のためのビタミンd誘導体及び抗増殖薬の併用
US20100009949A1 (en) * 2006-03-24 2010-01-14 Bioxell S.P.A. Novel method
CN101754971A (zh) * 2007-05-30 2010-06-23 赛特克罗公司 氧化膦维生素d前体的制备方法
LT2708559T (lt) 2008-04-11 2018-06-11 Chugai Seiyaku Kabushiki Kaisha Antigeną surišanti molekulė, galinti pakartotinai prisijungti prie dviejų ar daugiau antigeno molekulių
EP2682386B1 (en) * 2011-03-02 2016-08-17 Nihon University Novel vitamin d receptor modulator with partial agonist activity
KR102523660B1 (ko) 2016-09-26 2023-04-19 (주)하이플 박스용 테두리 부재보강부재와 에셈블리컨테이너 원터치크립이 포함된 박스

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4749710A (en) 1985-05-01 1988-06-07 Hoffmann-La Roche Inc. Immunosuppressive agents
ZA8923B (en) * 1988-01-20 1989-09-27 Hoffmann La Roche 16-dehydro-vitamin d3-derivatives
US5087619A (en) * 1988-01-20 1992-02-11 Hoffman-La Roche Inc. Vitamin D3 analogs
CA2096105A1 (en) * 1992-10-07 1994-04-08 Enrico Giuseppe Baggiolini (Deceased) Vitamin d3 fluorinated analogs
US5401733A (en) * 1993-10-01 1995-03-28 Hoffmann-La Roche Inc. Stable and active metabolites of 1,25-dihydroxy-16-ene-cholecalciferol
US5428029A (en) * 1993-11-24 1995-06-27 Hoffmann-La Roche Inc. Vitamin D3 fluorinated analogs
US6040300A (en) * 1995-04-07 2000-03-21 Arch Development Corporation Method of preventing colon cancer with vitamin D3 analogues
AU708679B2 (en) 1996-03-21 1999-08-12 F. Hoffmann-La Roche Ag 1,25-dihydroxy-16,22,23-trisdehydro-cholecalciferol derivatives

Also Published As

Publication number Publication date
CO5190683A1 (es) 2002-08-29
JP2003504354A (ja) 2003-02-04
AU6689400A (en) 2001-01-30
JO2255B1 (en) 2004-10-07
MXPA02000313A (es) 2002-06-21
NO20020161D0 (no) 2002-01-11
PE20010328A1 (es) 2001-03-22
DE60009303D1 (de) 2004-04-29
US6331642B1 (en) 2001-12-18
EP1200399B1 (en) 2004-03-24
GC0000198A (en) 2006-03-29
IL147254A (en) 2006-07-05
KR20020033728A (ko) 2002-05-07
AU779408B2 (en) 2005-01-20
HK1047578A1 (en) 2003-02-28
AR024695A1 (es) 2002-10-23
KR100477161B1 (ko) 2005-03-18
WO2001004089A1 (en) 2001-01-18
TR200200054T2 (tr) 2002-06-21
PT1200399E (pt) 2004-06-30
JP3803579B2 (ja) 2006-08-02
RU2235721C2 (ru) 2004-09-10
MY122633A (en) 2006-04-29
ZA200110487B (en) 2003-03-20
HRP20020007A2 (en) 2003-04-30
IL147254A0 (en) 2002-08-14
ATE262508T1 (de) 2004-04-15
HUP0202157A3 (en) 2004-04-28
HUP0202157A2 (en) 2002-10-28
BR0012419A (pt) 2002-03-26
DE60009303T2 (de) 2005-02-24
ES2215707T3 (es) 2004-10-16
CN1360572A (zh) 2002-07-24
UY26239A1 (es) 2000-10-31
EP1200399A1 (en) 2002-05-02
CA2378803C (en) 2009-01-27
PL356124A1 (pl) 2004-06-14
CA2378803A1 (en) 2001-01-18
NZ516339A (en) 2003-07-25
CN1174964C (zh) 2004-11-10
EG23909A (en) 2007-12-30
MA26808A1 (fr) 2004-12-20
HK1047578B (zh) 2005-04-29
PL201877B1 (pl) 2009-05-29
NO20020161L (no) 2002-01-11
RS50229B (sr) 2009-07-15
YU92701A (sh) 2004-09-03
TWI268276B (en) 2006-12-11

Similar Documents

Publication Publication Date Title
DK1124779T3 (da) D-vitaminanaloge forbindelser
DK1235777T3 (da) Vitamin D-analoger
NO994094D0 (no) Stigerörsanordning
ID26447A (id) Turunan eritropoietin
ATA51899A (de) Handstempel
NO20003914D0 (no) Sintermaterialer
DE69935620D1 (de) Aufzug
ATE357433T1 (de) 4-pyrimidinyl-n-acyl-l-phenylanine
DK0808833T3 (da) D3-vitamin-analoger
DK1200399T3 (da) Vitamin D3-analoger
ATE297895T1 (de) 4-pyridinyl-n-acyl-l-phenylalanine
DK1235824T3 (da) D-vitaminanaloge forbindelser
DE50005038D1 (de) Vorsteuergerät
DE69932640D1 (de) Fahrtreppe
ID30214A (id) Turunan resorsinol
PT1167260E (pt) Derivados de vitamina d3
DE60007483D1 (de) Aufzug
DE50002350D1 (de) Hubschrauber
NO20021850D0 (no) Hygromycinderivater
ATA121799A (de) Ausbeulgerät
PL356301A1 (pl) Nowe analogi witaminy D
ATA107599A (de) Heizwasserbereiter
DE60010173D1 (de) Schlichtevorrichtung
AT500658A3 (de) Isolierplatte
DK199900287U3 (da) Trappestok